Auxetics is a company driven by biomechanics, committed to developing a venous stent that addresses the unique biomechanical properties of veins. Over the past three decades, stents have primarily focused on radial force and flexibility as their dominant characteristics. However, through a thorough examination of the biomechanical characteristics inherent to veins, the founders of Auxetics have formulated a groundbreaking approach to endovascular stenting.
Venous thromboembolic disease is a global health concern, afflicting millions of patients each year. Those suffering from the chronic aftermath of venous disease, such as post-thrombotic syndrome, may find some measure of relief through venous stenting. However, despite significant efforts, the long-term outcomes of venous stents in post-thrombotic syndrome remain largely unchanged, posing a pressing and unaddressed challenge.